JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
PDF Solutions
PDFS
$1.94B
| $4.93M | ﹤0.01% |
109,264
+29,092
| +36% | +$1.19M |
|
2752
Tandem Diabetes Care
TNDM
$1.33B
| $4.92M | ﹤0.01% |
200,651
+56,565
| +39% | +$1.82M |
|
2753
CALL
Cintas
CTAS
$81.9B
| $4.92M | ﹤0.01% |
39,600
| – | – |
|
2754
Vanguard Long-Term Bond ETF
BLV
$5.71B
| $4.92M | ﹤0.01% |
65,665
-2,012
| -3% | -$151K |
|
2755
ANI Pharmaceuticals
ANIP
$1.8B
| $4.91M | ﹤0.01% |
91,212
+47,673
| +109% | +$2.11M |
|
2756
Cheesecake Factory
CAKE
$5.05B
| $4.91M | ﹤0.01% |
141,972
+3,855
| +3% | +$128K |
|
|
PPL
2757
PUT
PPL Corp
PPL
$26.5B
| $4.91M | ﹤0.01% |
185,400
| – | – |
|
2758
CALL
Constellation Brands
STZ
$22.2B
| $4.9M | ﹤0.01% |
+19,900
| New | +$4.66M |
|
2759
Gentherm
THRM
$1.24B
| $4.89M | ﹤0.01% |
86,484
+4,691
| +6% | +$270K |
|
2760
Frontline
FRO
$8.79B
| $4.88M | ﹤0.01% |
335,663
-1,560,888
| -82% | -$23.3M |
|
2761
PUT
Pfizer
PFE
$143B
| $4.87M | ﹤0.01% |
132,800
-530,300
| -80% | -$20.6M |
|
2762
Opendoor
OPEN
$3.62B
| $4.87M | ﹤0.01% |
1,251,072
+828,458
| +196% | +$1.8M |
|
2763
First Trust Preferred Securities and Income ETF
FPE
$6.33B
| $4.87M | ﹤0.01% |
304,668
+121,917
| +67% | +$1.94M |
|
2764
QuinStreet
QNST
$889M
| $4.86M | ﹤0.01% |
550,324
-21,725
| -4% | -$219K |
|
2765
Atlantic Union Bankshares
AUB
$6.02B
| $4.85M | ﹤0.01% |
187,031
-750,454
| -80% | -$21.2M |
|
2766
CALL
PG&E
PCG
$38.3B
| $4.85M | ﹤0.01% |
280,600
+100,000
| +55% | +$1.69M |
|
2767
CALL
Gaming and Leisure Properties
GLPI
$12.6B
| $4.85M | ﹤0.01% |
100,000
-88,100
| -47% | -$4.39M |
|
2768
RXO
RXO
$3.37B
| $4.84M | ﹤0.01% |
213,510
+123,947
| +138% | +$2.5M |
|
2769
Qfin Holdings
QFIN
$1.68B
| $4.84M | ﹤0.01% |
280,032
+48,621
| +21% | +$818K |
|
2770
Takeda Pharmaceutical
TAK
$54.7B
| $4.83M | ﹤0.01% |
307,531
+233,423
| +315% | +$3.82M |
|
2771
iShares Micro-Cap ETF
IWC
$1.44B
| $4.83M | ﹤0.01% |
44,173
+340
| +0.8% | +$35.7K |
|
2772
Carriage Services
CSV
$641M
| $4.83M | ﹤0.01% |
148,682
+18,320
| +14% | +$513K |
|
2773
Celestica
CLS
$38.1B
| $4.82M | ﹤0.01% |
332,618
-22,153
| -6% | -$274K |
|
2774
Amphastar Pharmaceuticals
AMPH
$875M
| $4.82M | ﹤0.01% |
83,848
-33,919
| -29% | -$1.5M |
|
2775
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
| $4.81M | ﹤0.01% |
52,376
-8,280
| -14% | -$759K |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.